Hospital del Mar Research Institute Hospital del Mar Research Institute

News

17/11/2026 - Institutional news

A project to create a comprehensive atlas of human skin receives an ERC Synergy grant from the European Union

The DevSkin project, involving Hospital del Mar Research Institute researcher Maria Colomé-Tatché, will receive nearly 10 million euros from the European Research Council to advance our understanding of human skin and generate organoids derived from different skin regions, potentially enabling the development of new treatments.

The ERC Synergy Grants, awarded by the European Research Council (ERC), have selected the DevSkin project to receive nearly 10 million euros, of which 2.3 million euros will be allocated to HMRIB, to advance our understanding of human skin. The initiative involves Maria Colomé-Tatché, principal investigator of the Computational Epigenetics Group within the Biomedical Informatics Research Programme at HMRIB and GRIB (a joint research group between HMRIB and Pompeu Fabra University). Researchers from Claude Bernard University Lyon in France, the Wellcome Sanger Institute in Cambridge in the United Kingdom, and Brigham and Women's Hospital in Boston in the United States are also participating in the project.

This project aims to generate a comprehensive reference atlas of human skin development to use as a model for designing in vitro skin specific to each region of the body. Currently, the molecular rules that make skin different depending on its location on the body are unknown. The researchers will use single-cell and spatial multiomics technologies, 3D light-sheet imaging techniques and artificial intelligence-based data analysis to overcome this barrier.

Maria Colomé-Tatché.

"Our goal is to uncover the mechanisms that regulate human skin development", explains Maria Colomé-Tatché, who adds that this "will allow us to translate this knowledge into targeted therapeutic innovation". DevSkin aims to provide a comprehensive foundation for understanding human skin development, which could have a direct impact on the treatment of congenital skin disorders in childhood and adulthood. Furthermore, this knowledge should enable more accurate in vitro modelling of diseases and contribute to advances in regenerative engineering for future therapeutic applications.

The results that the project leaders aim to achieve include the creation of region-specific skin organoids, which will facilitate the availability of grafts tailored to each patient. This knowledge "could redefine our understanding of human skin, moving from descriptive analysis to the mechanistic reconstruction of tissue identity", explains Colomé-Tatché. At the same time, DevSkin will create a powerful platform through which industry can generate models of specific diseases and carry out drug screening, accelerating their application in precision dermatology and wound treatment.

ERC Synergy Grants

ERC Synergy Grants are awarded by the European Research Council (ERC), an organisation established by the European Union in 2007. In this edition, 957 projects were evaluated, of which 48 were selected. The ERC is the leading funding body for high-level and advanced research in Europe, with a budget of more than 16 billion euros for the period 2021-2027. It is part of the EU's Horizon programme. Its mission is to promote high-quality research across Europe through competitive funding and to support frontier research led by researchers from all fields, based on scientific excellence.

More news

Contact

Servei de Comunicació:
Marta Calsina(ELIMINAR)

Tel:
(+34) 93 316 06 80

Doctor Aiguader, 88
08226 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact